Cargando…
Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?
Immunotherapy (IO) has altered the therapeutic landscape for multiple cancers. There are emerging data from retrospective studies on a subset of patients who do not benefit from IO, instead experiencing rapid progression with dramatic acceleration of disease trajectory, termed ‘hyperprogressive dise...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726601/ https://www.ncbi.nlm.nih.gov/pubmed/32101722 http://dx.doi.org/10.1016/j.trecan.2020.01.005 |